Searchable abstracts of presentations at key conferences in endocrinology

ea0044p19 | Adrenal and Steroids | SFEBES2016

Adrenal crisis – an important endocrine emergency needing ongoing education

Gemma Rodriguez Carnero Maria , San Yap Pui , Hesarghatta, Alison Milne Asha , Graveling Alex , Philip Sam , Abraham Prakash

Aims: Adrenal crisis (AC) is a life- threatening condition with an incidence of 6–10 adrenal crises per 100 patient year in European populations. The aim of our study is to identify the prevalence of adrenal crisis in our clinic population and assess the preventative measures in use.Methods: Data was obtained from electronic records and paper records were reviewed in adrenal crisis patients.Results: There were 230 patients wit...

ea0044p49 | Bone and Calcium | SFEBES2016

The impact of primary hyperparathyroidism and its treatment on bone mineral density, bone mineral parameters, insulin resistance, body composition and quality of life – A prospective pilot study from India

Paul Thomas V , Shetty Shrinath , Kapoor Nitin , Shetty Sahana , Paul M J , Abraham Deepak , Ramakant Pooja , Dian Joseph , Thomas Nihal

Aims: To study changes in bone mineral density (BMD), bone mineral parameters, metabolic profile, body composition and quality of life at base line and 6 months following parathyroidectomy, in subjects with primary hyperparathyroidism (PHPT).Material and methods: This prospective study was conducted over 18 months with first 12 months of recruitment and next 6 months for follow-up. Sixty-eight patients with PHPT who underwent surgery were compared with 1...

ea0044p135 | Neoplasia, cancer and late effects | SFEBES2016

The effect of peptide receptor radionuclide therapy (PRRT) on symptoms and tumour burden in patients with metastatic neuroendocrine tumour (NET)

Abraham Stalin , Casey Ruth , Challis Ben , Pitfield Deborah , Whitley S , Shaw Ashley , Heard Sarah , Saad Zia , Buscombe John , Simpson Helen

Peptide receptor radionuclide therapy (PRRT) is a targeted therapy using synthetic somatostatin analogues attached to a radionuclide, which binds to tumours expressing somatostatin receptors. The aim was to review the role of PRRT in a tertiary referral centre. We retrospectively reviewed a cohort of 25 patients (eight males, 17 females), with a median age of 65, who received Yttrium-90 DOTATATE or Lutetium-177 DOTATATE at Addenbrookes Hospital. The location of the primary tum...

ea0013p200 | Endocrine tumours and neoplasia | SFEBES2007

Bone metastases in papillary carcinoma thyroid and the role of I-131 ablation

Paul Thomas , Thomas Nihal , Seshadri Mandalam , Kumar Kishore , Selvan Ben , Nair Aravindan , Oommen Regi , Shanthly Nylla , Abraham Deepak

Aim: To study patients with Bone metastases in papillary carcinoma thyroid and the role of I-131 ablation.Methods: Retrospective analysis of patients with papillary carcinoma of thyroid between 1960–2005 in our institution.Results: Of 1538 patients who had thyroid carcinoma, papillary carcinoma was seen in 1228 (79.8%), and 21 patients with papillary carcinoma (1.71%) had bone metastases. Seventy percent of them were between 4...

ea0011p910 | Thyroid | ECE2006

Changes in thyroxine requirement in the long-term follow-up of hypothyroid patients

Viswanath AK , Avenell A , Philip S , Acharya S , MacLennan G , Dalziel K , Copland SA , Bevan JS , Abraham P

Background and methodology: There are few data on changes in thyroxine requirement in the long-term follow-up of hypothyroid patients. We carried out a retrospective analysis to evaluate the long-term changes in thyroxine dose and its relationship with age, gender, thyroxine dose at registration and aetiology of hypothyroidism.Results: We identified 5,029 patients from our hospital based thyroid register with a minimum of 4 years follow-up (88% female, 7...

ea0011p913 | Thyroid | ECE2006

What is the most effective screening interval in the long-term follow-up of stable hypothyroid patients on thyroxine?

Viswanath AK , Avenell A , Philip S , Acharya S , MacLennan G , Dalziel K , Pereira O , Copland SA , Bevan JS , Abraham P

Background and methodology: In the long-term surveillance of treated hypothyroid patients, annual surveillance (with thyroid function testing) is widely recommended. This is largely based on consensus, as there is limited evidence to support this practice. Currently around 20,000 patients are registered in our hospital based thyroid register and the majority are on 18 monthly follow-up. We carried out a retrospective analysis to see if there is evidence to support increased fr...

ea0003p48 | Clinical Case Reports | BES2002

Multidisciplinary management of Cushing's syndrome due to a malignant thymic carcinoid tumour

Park C , Watson W , Abraham P , Acharya S , Bandyopadhyay S , Philip S , Samuel L , Nicolson M , Bevan J

Thymic carcinoma is a rare but aggressive cause of ectopic ACTH secretion, with fewer than 100 reported cases.Hypokalaemic alkalosis was found in a 38 year old woman who presented with a 2-week history of leg swelling, fatigue and dyspnoea. She was not obviously Cushingoid.ACTH-dependent Cushing's Syndrome was confirmed biochemically: urinary free cortisol (UFC) >8500nmol/day and serum cortisol 4060nmol/l, (no suppression on 8...

ea0003p148 | Endocrine Tumours and Neoplasia | BES2002

Primary medical management of macroprolactinomas with cabergoline(CAB)

Philip S , Booth A , Abraham P , Kumaravel M , Watson W , Park C , Bandyopadhyay S , Acharya S , Bevan J

Objective: To establish the efficacy of CAB as primary and exclusive therapy in the management of macroprolactinomasMethod: Retrospective case note review of all patients with macroprolactinomas treated with CAB since the drug received a UK licence in 1994. Patients: Sixteen patients (8males, 8 females) with mean age at presentation of 42.3yrs (range 22-72 years) were treated with initial CAB doses ranging from 0.5-1mg/week (median 1mg/week). Results: T...

ea0003p150 | Endocrine Tumours and Neoplasia | BES2002

Patterns and mechanisms of hypercortisolism in association with phaeochromocytoma

Abraham P , Watson W , Park C , Philip S , Bandyopadhyay S , Acharya S , Talbot J , White A , Bevan J

Phaeochromocytoma in association with hypercortisolism is thought to be rare. However we have observed 4 cases in 3 years and question the rarity of this link. In each case there was a dominant adrenal mass (3.6-7.7cm) with contralateral adrenal hyperplasia. Three of the 4 tumours showed increased 123-I-mIBG uptake. Urinary catecholamines ranged from 872-22752nmol/24h (N < 600). Hypercortisolism was present in all 4 patients; sustained in 2 and cyclical in 2. Case 1 (JCEM ...

ea0081p341 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Impact of the mode of insulin delivery on the quality of life of type 1 diabetes patients

Tzivian Lilian , Sokolovska Jelizaveta , Grike Anna E. , Kalcenaua Agate , Seidmann Abraham , Benis Arriel , Mednis Martins , Danovska Ieva , Berzins Ugis , Bogdanovs Arnolds , Syundyukov Emil

Background: Insulin pump therapy is an alternative to multiple daily injections and can improve glycemic control and quality of life (QoL) in Type 1 diabetes mellitus (T1DM) patients. The aim of this study was to assess the differences and factors related to the T1DM-specific QoL of T1DM patients in Latvia.Methods: 87 adult patients with T1DM were included. Of them, 20 were pump users and 67 were users of injections. All recruited patients participated i...